Projects per year
Personal profile
Education
- 1998 Ph.D., National Cheng Kung University
Research Interests
- Hepatitis virus and Lipid metabolism
- Metabolism of lipid and lippoprotein
- development of diagnostic kits and POCT devices
Experience
- 2016~~present Chairman, Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan
- 2012~present Professor, Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan
- 2001~2002 Visiting Professor, University of Southern California, U.S.A
- 1999~2012 Associate Professor, Department of Medical Laboratory Science and Biotechnology, National Cheng-Kung University
- 1991~1999 Instructor, Department of Medical Technology, National Cheng Kung University, Tainan, Taiwan
- 1990~1991 Assistant Professor, Department of Medical Laboratory Science and Biotechnology, National Cheng-Kung University
Fingerprint
Dive into the research topics where Kung-Chia Young is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Research Output
-
Differential dynamics of hepatic protein expressions with long-term cultivated hepatitis C virus infection
Tsai, P., Lin, T. Y., Cheng, S. L., Sun, H. Y., Chen, S. F. & Young, K. C., 2020 Oct, In: Journal of Microbiology, Immunology and Infection. 53, 5, p. 715-723 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Etifoxine, a TSPO Ligand, Worsens Hepatitis C-Related Insulin Resistance but Relieves Lipid Accumulation
Lin, Y. M., Sun, H. Y., Chiu, W. T., Su, H. C., Chien, Y. C., Chang, H. A., Chong, L. W., Chang, H. C., Young, K. C., Bai, C. H. & Tsao, C. W., 2019, In: BioMed research international. 2019, 3102414.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Plasma proteome plus site-specific N-glycoprofiling for hepatobiliary carcinomas
Chang, T. T., Cheng, J. H., Tsai, H. W., Young, K. C., Hsieh, S. Y. & Ho, C. H., 2019 Jul, In: Journal of Pathology: Clinical Research. 5, 3, p. 199-212 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Calcitriol inhibits HCV infection via blockade of activation of PPAR and interference with endoplasmic reticulum-associated degradation
Lin, Y. M., Sun, H. Y., Chiu, W. T., Su, H. C., Chien, Y. C., Chong, L. W., Chang, H. C., Bai, C. H., Young, K. C. & Tsao, C. W., 2018 Feb, In: Viruses. 10, 2, 57.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection
Sun, H. Y., Cheng, P. N., Tseng, C. Y., Tsai, W. J., Chiu, Y. C. & Young, K. C., 2018 Jan 1, In: Gut. 67, 7, p. 1342-1350 9 p.Research output: Contribution to journal › Article › peer-review
10 Citations (Scopus)